Γ—

1E Therapeutics

Organization Description

1E Therapeutics (previously known as Hanako) is a breakthrough drug development company based in Israel. They are creating a novel class of programmable oligonucleotide therapeutics, designed to treat humanity’s most intractable diseases by autonomously and precisely silencing disease-causing RNAs in human or pathogen cells.

To do this, we need your support. Your charitable contribution tranforms into rejuvenation research, news, shows, and more. Will you help?